Stock ELOX ELOXX PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Eloxx Pharmaceuticals, Inc.

Equities

ELOX

US29014R2022

Market Closed - OTC Markets
Other stock markets
 19:09:45 03/05/2024 BST 		5-day change 1st Jan Change
0.9 USD +5.88% Intraday chart for Eloxx Pharmaceuticals, Inc. +11.69% -25.00%
04-11 North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge DJ
03-13 Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases CI

Chart calendar Eloxx Pharmaceuticals, Inc.

6b6b105844af12e787080.NKp4YQjdmaEF7d8M9C1hB77fSw56WyW5hb7_CLboRcs.BJoBUTzp3OI1t5w5uEoyfo-4fX1KDH3918qQV4-OBKJzySJXQ4fD83Kkjg~f23cea05456e22fc5071ab2adaf98eab

Upcoming events on Eloxx Pharmaceuticals, Inc.

08/05/2024 Q1 2024 Earnings Release (Projected)
06/08/2024 Q2 2024 Earnings Release (Projected)
06/11/2024 Q3 2024 Earnings Release (Projected)

Past events on Eloxx Pharmaceuticals, Inc.

13/11/2023 21:15 Q3 2023 Earnings Release
14/08/2023 13:30 Q2 2023 Earnings Release
27/06/2023 16:30 Investor Day - Key Opinion Leader
22/06/2023 17:00 Annual General Meeting
15/05/2023 21:30 Q1 2023 Earnings Release
03/04/2023 13:00 Q4 2022 Earnings Release
13/03/2023 16:00 Oppenheimer Healthcare Conference
01/12/2022 Reverse Split: 1 of 40
30/11/2022 15:00 Extraordinary Shareholders Meeting
10/11/2022 22:15 Q3 2022 Earnings Release
14/09/2022 21:30 ELX-02 in Class 1 Cystic Fibrosis Phase 2 Trial Results Call
15/08/2022 13:00 Interim 2022 Earnings Release
15/06/2022 18:00 Annual General Meeting
10/05/2022 13:00 Q1 2022 Earnings Release
31/03/2022 12:00 FY 2021 Earnings Release
09/01/2022 H.C. Wainwright BIOCONNECT Virtual Conference
17/11/2021 13:30 ELX-02 Phase 2 Clinical Trial Results Call
09/11/2021 13:00 Q3 2021 Earnings Release
12/10/2021 15:00 Business Update Call
16/08/2021 21:05 Interim 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-47,6
-44,6
-6.75%		-50,6
-53,1
4.73%		-33,5
-36,3
7.9%		-66,0
-65,1
-1.4%		-34,4
-35,0
1.66%
0,00

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-47,1
-44,5
-5.64%		-50,9
-53,3
4.56%		-34,6
-37,3
7.3%		-66,7
-64,8
-3.01%		-36,1
-36,5
1.19%
0,00

Net income
Million USD		Released
Forecast
Spread 		-47,2
-44,5
-5.92%		-50,9
-53,3
4.56%		-34,6
-37,3
7.3%		-66,7
-64,8
-3.01%		-36,1
-36,5
1.19%
0,00

EPS
USD		Released
Forecast
Spread 		-58,0
-55,4
-4.72%		-53,6
-55,8
3.98%		-34,4
-37,0
7.03%		-38,0
-37,6
-1.06%		-666
-16,6
-3902.4%
-7,91

Announcement Date08/03/1906/03/2012/03/2130/03/2231/03/23-

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
3,50
- 		0,00
2,33
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,70
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-10,2
-10,5
2.46%		-11,6
-10,7
-8.54%		-11,0
-7,31
-49.86%		-10,3
-8,82
-16.67%		-7,14
-9,50
24.82%		-6,03
-6,61
8.79%		-5,48
-5,30
-3.45%		-4,14
-5,00
17.2%		-3,64
-4,00
9.08%


Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-9,89
-10,8
8.81%		-12,1
-10,4
-15.92%		-11,6
-7,43
-56.45%		-10,6
-9,17
-15.84%		-7,51
-9,90
24.16%		-6,32
-6,75
6.44%		-6,23
-5,60
-11.25%		-4,34
-5,30
18.09%		-3,59
-4,40
18.36%


Net income
Million USD		Released
Forecast
Spread 		-9,89
-10,8
8.08%		-12,1
-10,4
-15.92%		-11,6
-7,43
-56.45%		-10,6
-9,17
-15.84%		-7,51
-9,90
24.16%		-6,32
-6,75
6.44%		-6,23
-5,60
-11.25%		-4,34
-5,30
18.09%		-3,59
-4,40
18.36%


EPS
USD		Released
Forecast
Spread 		-4,40
-5,40
18.52%		-4,00
-4,80
16.67%		-5,20
-3,70
-40.54%		-4,80
-4,13
-16.13%		-3,60
-4,40
18.18%		-3,05
-2,97
-2.69%		-2,88
-2,55
-12.94%		-1,96
-1,54
-27.27%		-1,31
-1,97
33.5%
-1,43

Announcement Date08/11/2130/03/2206/05/2212/08/2210/11/2231/03/2312/05/2311/08/2313/11/23-

Upcoming sector events for Eloxx Pharmaceuticals, Inc.

05/05/2024 FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected)
05/05/2024 KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release
05/05/2024 MERUS N.V.: Q1 2024 Earnings Release (Projected)
05/05/2024 VAXCYTE, INC.: Q1 2024 Earnings Release (Projected)
05/05/2024 INHIBRX, INC.: Q1 2024 Earnings Release (Projected)
05/05/2024 BIONTECH SE: Q1 2024 Earnings Release
06/05/2024 12:00 BIOCRYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
06/05/2024 21:01 VERTEX PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release
06/05/2024 COGENT BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected)
06/05/2024 LYELL IMMUNOPHARMA, INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Eloxx Pharmaceuticals, Inc.

03/05/2024 12:00 GH RESEARCH PLC: Q1 2024 Earnings Release
02/05/2024 21:05 KURA ONCOLOGY, INC.: Q1 2024 Earnings Release
02/05/2024 21:05 ZYMEWORKS INC.: Q1 2024 Earnings Release
02/05/2024 21:02 ARDELYX, INC.: Q1 2024 Earnings Release
02/05/2024 21:01 LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
02/05/2024 21:01 ASCENDIS PHARMA A/S: Q1 2024 Earnings Release
02/05/2024 21:00 ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release
02/05/2024 16:00 GENMAB A/S: Q1 2024 Earnings Release
02/05/2024 12:00 GERON CORPORATION: Q1 2024 Earnings Release
02/05/2024 12:00 AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ELOX Stock
  4. Calendar Eloxx Pharmaceuticals, Inc.